Publications

Specialty Oral Anticancer Prescription Fill Rates After Medicare Part D Cost-Sharing Changes in 2024

JAMA Network

December 29, 2025

John K Lin, Pengxiang Li, Xiudong Lei, Sunita M Desai, Jalpa A Doshi

CAR-T for all? Barriers, facilitators, and interventions to commercial CAR T-cell therapy access

Blood Reviews

December 16, 2025

Sofia Kaparis, Khashayar Eshaghi, Luca Paruzzo, Jalpa Doshi, Marco Ruella, Carmen E Guerra

Medicaid Coverage and Prior Authorization for Antiobesity Glucagon-Like Peptide-1 Receptor Agonists: A Cross-Sectional Study of State Policies

Journal of General Internal Medicine

November 21, 2025

Matthew J Klebanoff, Ashwin K Chetty, Jalpa A Doshi

Medicare Part D Coverage and Costs for Glucagon-Like Peptide-1 Receptor Agonists

JAMA

September 24, 2025

Matthew J. Klebanoff, Pengxiang Li, Judith A. Long, Jalpa A. Doshi

Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple Sclerosis

Neurology Clinical Practice

September 16, 2025

Pengxiang Li, John K Lin, Matthew J Klebanoff, Riya Palkar, Salim Chahin, Jalpa A Doshi

Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare Fee-for-Service Beneficiaries With Metastatic Breast, Colorectal, Lung, and Prostate Cancers

Journal of Clinical Oncology

August 27, 2025

John K Lin, Jiangong Niu, Sharon H Giordano, Pengxiang Li, Rebecca A Snyder, Kaiping Liao, Meng Li, Ana Aparicio, William Chapin, Jianjun Zhang, Jenny Xiang, Nirosha Perera, Debanjan Pain, Carmen E Guerra, Jalpa A Doshi

Inflation Reduction Act Provisions and Medicare Part D Out-of-Pocket Costs for Specialty Drugs

JAMA Health Forum

May 16, 2025

Jalpa A Doshi, Pengxiang Li, Matthew J Klebanoff, John K Lin

Reducing Medicare Part D Out-of-Pocket Costs for Specialty Oral Anticancer Drugs Under the Inflation Reduction Act: Highlighting the Benefits of Enrolling in the Medicare Prescription Payment Plan

JCO Oncology Practice

April 25, 2025

Jalpa A Doshi, Pengxiang Li, Shravan Asthana, John K Lin

Opioid Cap Laws and Opioid Prescriptions After Total Joint Replacements in Older Adults

JAMA Network Open

April 9, 2025

Caroline P Thirukumaran, Derek T Schloemann, Jalpa A Doshi, Kevin A Fiscella, Benjamin F Ricciardi, Meredith B Rosenthal

Real-World Effectiveness of Long-Acting Injectable and Oral Antipsychotic Agents in US Medicare Patients with Schizophrenia

Advances in Therapy

January 15, 2025

Pengxiang Li, Zhi Geng, Carmela Benson, Charmi Patel, Jalpa A Doshi

County-Level Factors Associated with Reversal of Insurer-Approved HIV Pre-Exposure Prophylaxis Prescriptions in the United States, 2018

AIDS and Behavior

December 30, 2024

Rahel Dawit, William C. Goedel, Hsien-Yen Chang, Amy S. Nunn, Philip A. Chan, Jalpa A. Doshi & Lorraine T. Dean

Real-World Treatment Patterns After Discontinuation of Venetoclax or BTKis in the Frontline Setting Among Older Adults With Chronic Lymphocytic Leukemia

JCO Oncology Practice

December 20, 2024

Scott F Huntington, Joanna M Rhodes, Beenish S Manzoor, Dureshahwar Jawaid, Justin T Puckett, Nnadozie Emechebe, Arliene Ravelo, Sachin Kamal-Bahl, Steven E Marx, Jalpa A Doshi

Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices

Forum for Health Economics and Policy

November 8, 2024

Jason Shafrin, Jaehong Kim, Joshua T Cohen, Louis P Garrison, Dana A Goldman, Jalpa A Doshi, Joshua Krieger, Darius N Lakdawalla, Peter J Neumann, Charles E Phelps, Melanie D Whittington, Richard Willke

Real-Time Prescription Benefit Tool Adoption Among US Hospitals

JAMA Health Forum

October 4, 2024

Matthew J Klebanoff, Pengxiang Li, Paula Chatterjee, Jalpa A Doshi

Clinician Specialty and HIV PrEP Prescription Reversals and Abandonments

JAMA Network

August 19, 2024

Shivani Bakre, Hsien-Yen Chang, Jalpa A Doshi, William C Goedel, Parya Saberi, Philip A Chan, Amy Nunn, Lorraine T Dean

Real-world comparison of health care costs of venetoclax-obinutuzumab vs Bruton’s tyrosine kinase inhibitor use among US Medicare beneficiaries with chronic lymphocytic leukemia in the frontline setting

JMCP

July 24, 2024

Scott F Huntington, Beenish S Manzoor, Dureshahwar Jawaid, Justin T Puckett, Nnadozie Emechebe, Arliene Ravelo, Sachin Kamal-Bahl, Jalpa A Doshi